complement
natur
occur
genet
mechan
studi
number
plusstrand
rna
virus
although
transcomplement
well
document
flavivirida
famili
virus
first
system
hepat
c
viru
hcv
describ
sinc
develop
number
hcv
transcomplement
model
improv
knowledg
hcv
protein
function
interact
genom
replic
viral
particl
assembl
model
also
use
produc
defect
virus
improv
necessari
vaccin
assay
review
provid
updat
hcv
transcomplement
system
viral
mechan
studi
therewith
product
character
transencapsid
particl
complement
natur
occur
genet
mechan
enabl
function
rescu
defect
mutant
genom
phenomenon
use
vitro
assay
convent
complement
experi
defect
genom
protein
rescu
wildtyp
wt
copi
fig
virolog
complement
genom
tool
use
investig
protein
function
viral
particl
assembl
establish
whether
genom
replic
occur
preferenti
cisact
mechan
moreov
model
also
use
produc
defect
virus
variou
purpos
flavivirida
positivestrand
rna
virus
replic
genom
virusinduc
vesicular
compart
membran
complex
rather
enclos
structur
tend
limit
exchang
viral
rna
protein
transcomplement
moreov
number
plusstrand
rna
virus
rang
viru
famili
picornavirida
polioviru
alphavirida
sindbi
viru
semliki
forest
viru
venezuelan
equin
enceph
viru
coronavirida
human
coronaviru
flavivirida
tickborn
enceph
viru
kunjin
viru
west
nile
viru
yellow
fever
viru
assembl
progeni
virus
achiev
structur
protein
express
tran
independ
rna
molecul
encod
replicas
protein
particl
infecti
capabl
singl
round
infect
viral
transencapsid
system
may
also
use
vaccin
deliveri
system
concern
hcv
research
report
presenc
natur
hcv
subgenom
rna
serum
liver
tissu
infect
patient
subgenom
rna
contain
larg
infram
delet
alway
found
togeth
fulllength
wt
rna
mutant
viral
genom
persist
least
year
sequenc
analysi
suggest
subgenom
fulllength
hcv
rna
evolv
independ
rel
abund
persist
subgenom
rna
vivo
suggest
capabl
autonom
replic
packag
secret
infecti
viral
particl
first
hcv
transcomplement
studi
concern
replic
complex
next
develop
cellculturegrown
hepat
c
viru
hcvcc
system
assembl
releas
infecti
viral
particl
made
possibl
studi
structur
region
use
transcomplement
system
furthermor
variou
transpackag
system
hcv
subgenom
replicon
rna
develop
first
transcomplement
studi
perform
appel
et
al
use
subgenom
replicon
hcv
type
embl
access
number
research
look
whether
lethal
mutat
nonstructur
ns
hcv
gene
could
rescu
transcomplement
seri
replicon
rna
carri
mutat
region
abolish
replic
transfect
hepatoma
cell
harbour
autonom
replic
hcv
helper
rna
context
mutat
low
complex
sequenc
lc
domain
effici
rescu
tabl
requir
protein
complement
wherea
express
alon
restor
rna
replic
find
strongli
suggest
ns
hcv
protein
specif
act
ci
hcv
rna
inde
hypothesi
confirm
tong
malcom
nevertheless
transact
function
like
would
requir
protein
hyperphosphoryl
addit
studi
show
delet
domain
iii
genom
hcv
chimer
type
abolish
replic
pseudoinfecti
particl
produc
therefor
cotransfect
delet
replicon
rescu
hcv
particl
product
tabl
taken
whole
result
elucid
key
role
domain
iii
hcv
assembl
process
jone
et
al
perform
firstli
transcomplement
use
variou
replicon
rna
carri
variou
replicationabolish
mutat
ctermin
domain
rna
rescu
replic
two
mutant
tabl
nevertheless
complement
effici
lowabout
vs
mutant
highli
conserv
amino
acid
predict
lie
within
unstructur
region
flank
helix
research
conclud
complement
limit
transcomplement
assay
also
use
studi
role
viral
particl
assembl
number
differ
delet
within
transmembran
segment
proteas
domain
chimera
genom
examin
tabl
replic
seen
absenc
pseudoinfecti
particl
product
three
bicistron
helper
rna
built
combin
replicas
modul
utr
code
region
express
modul
control
polioviru
intern
ribosom
entri
site
ire
variou
cotransfect
mutant
bicistron
helper
rna
perform
cell
three
mutant
could
rescu
transcomplement
infect
titr
obtain
rescu
experi
lower
wt
time
yi
et
al
studi
role
serin
amino
acid
aa
posit
viral
assembl
matur
process
found
substitut
alanin
glycin
aa
abolish
infecti
viru
product
polyprotein
process
genom
replic
tabl
howev
transfect
mutant
replicon
rna
cell
line
express
wt
rescu
product
infecti
viru
contrast
transfect
wt
type
cell
line
unabl
rescu
viru
product
although
cell
could
rescu
viral
product
chimera
mutant
rescu
partial
wt
cell
experi
perform
cell
line
express
carri
delet
ctermin
domain
infecti
particl
product
obtain
indic
ctermin
domain
major
determin
hcv
product
result
indic
wt
express
abl
transcompl
construct
genotypeand
straindepend
fig
schemat
represent
transcomplement
principl
virolog
mutant
defect
genom
rescu
wildtyp
copi
allow
product
infecti
particl
capabl
singl
round
infect
appel
et
al
jone
et
al
yi
et
al
conclus
transcomplement
base
ns
region
shown
region
carri
mutat
domain
delet
domain
iii
complement
minim
sequenc
ii
effici
transcompl
wt
iii
transcomplement
exist
mutat
unstructur
region
weak
use
hcvcc
system
produc
infecti
viral
particl
enabl
investig
core
protein
role
assembl
process
shown
core
ns
protein
local
within
lipid
droplet
ld
convers
lack
core
express
replic
cell
associ
diffus
distribut
ns
protein
endoplasm
reticulum
er
absenc
concentr
around
ld
moreov
ld
level
lower
replic
cell
wt
replic
cell
interestingli
ns
protein
accumul
around
ld
replic
cell
transfect
plasmid
express
wt
core
result
show
ldassoci
core
recruit
ns
protein
er
ld
moreov
core
activ
could
restor
transcomplement
parallel
kopp
et
al
use
transcomplement
assay
investig
role
core
ctermin
region
identifi
essenti
residu
involv
infecti
particl
product
mutat
introduc
residu
tabl
found
mutat
posit
abrog
pseudoinfecti
particl
product
despit
presenc
wildtyp
replic
level
contrast
cotransfect
replicon
contain
larg
delet
sequenc
code
core
protein
residu
fulllength
hcv
core
protein
plasmid
led
signific
level
pseudoinfecti
particl
releas
pseudoinfecti
particl
obtain
use
core
mutant
plasmid
context
transcomplement
system
highlight
import
residu
pseudoinfecti
particl
product
brohm
et
al
develop
complement
system
investig
key
determin
essenti
optim
function
hcv
infecti
particl
product
three
replicon
construct
one
delet
entir
code
region
full
second
lack
residu
half
third
carri
dual
mutat
highli
conserv
basic
residu
qq
tabl
replicon
full
half
unabl
gener
infecti
particl
replicon
fewer
infecti
particl
releas
parent
genom
defect
hcv
replicon
cotransfect
bicistron
helper
replicon
express
either
alon
alon
first
cistron
ns
protein
second
half
infect
rescu
helper
rna
express
wherea
signal
sequenc
influenc
howev
cotransfect
helper
rna
yield
higher
viru
titr
case
full
replicon
complement
achiev
coexpress
infect
rescu
helper
rna
although
pseudoinfecti
particl
product
increas
presenc
helper
rna
lastli
product
infecti
particl
seen
hcv
type
helper
replicon
indic
genotyp
specif
result
indic
proteindefici
replicon
could
rescu
express
protein
alon
conclus
transcomplement
structur
region
shown
core
transcompl
wt
core
transcompl
sequenc
express
alon
hcv
transencapsid
system
first
transencapsid
system
describ
packag
replicon
flaviviru
includ
kunjin
viru
yellow
fever
viru
tickborn
enceph
viru
west
nile
viru
viruslikeparticlegener
system
enabl
develop
vaccin
model
analysi
aspect
viral
assembl
entri
base
studi
variou
system
packag
hcv
replicon
creat
two
type
construct
use
transencapsid
system
minim
replicas
complex
fulllength
genom
carri
delet
envelopeencod
gene
tabl
first
studi
use
replicon
associ
either
resist
gene
neomycin
report
gene
renilla
luciferas
replicon
enabl
establish
stabl
cell
line
titrat
colonyform
unit
cfuml
select
effici
replic
cell
clone
rapid
infecti
particl
assay
could
perform
replicon
construct
use
adair
et
al
studi
role
particl
assembl
process
yield
highest
infecti
titr
masaki
et
al
suzuki
et
al
chose
use
cdna
clone
plasmid
contain
pol
promot
termin
sequenc
luciferas
gene
report
sequenc
directli
transfect
cell
without
need
transcript
step
tabl
anoth
approach
adopt
pacini
sugiyama
use
replicon
base
defect
genom
found
serum
liver
tissu
chronic
hcvinfect
patient
sugiyama
et
al
gener
chimera
base
defect
patient
isol
carri
delet
gene
code
envelop
protein
likewis
pacini
et
al
use
chimera
build
construct
variou
delet
glycoprotein
region
aa
aa
core
region
respect
tabl
lastli
sever
research
group
studi
replicon
carri
delet
aa
envelop
gene
tabl
encapsid
subgenom
replicon
partial
total
delet
structur
region
perform
variou
system
express
structur
protein
tran
tabl
presenc
absenc
protein
research
focus
replicon
helper
virus
direct
express
vector
wherea
other
establish
stabl
cell
line
baculoviru
lentiviru
deliveri
system
pacini
et
al
pacini
et
al
pacini
et
al
first
transencapsid
assay
perform
cell
via
transient
transfect
replicon
helper
virus
allow
reproduc
vitro
natur
transencapsid
mechan
vivo
similar
experi
heterolog
helper
virus
attempt
howev
given
competit
defect
replicon
helper
virus
difficult
obtain
equal
replic
high
transencapsid
effici
moreov
two
differ
marker
must
introduc
identifi
two
encapsid
replicon
research
chosen
structur
protein
express
plasmid
presenc
absenc
perform
transencapsid
determin
minim
sequenc
requir
effici
encapsid
variou
plasmid
construct
use
plasmid
encod
chimera
pcagc
plasmid
express
region
tabl
parallel
use
stabl
cell
line
improv
yield
pseudoinfecti
particl
plasmid
ishii
et
al
establish
stabl
cell
line
express
protein
respect
steinmann
et
al
cotransfect
lentivir
vector
express
protein
cell
respect
obtain
high
level
structur
protein
express
convers
stabl
cell
line
base
defect
replicon
resist
gene
use
select
effici
cell
clone
achiev
high
level
replic
latter
model
develop
express
complement
structur
protein
baculoviru
system
express
core
core
protein
lentiviru
system
express
core
although
transencapsid
assay
preferenti
perform
human
liverderiv
cell
line
ie
subclon
murin
hepat
cell
line
also
studi
twostep
develop
process
delet
replicon
helper
replicon
first
valid
transient
experi
adapt
stabl
cell
line
standard
improv
system
variou
research
thu
shown
transpackag
system
function
tabl
proven
replicon
packag
protein
express
tran
therefor
protein
essenti
infecti
particl
product
effici
transpackag
obtain
parallel
found
replicon
could
packag
region
howev
transpackag
effici
higher
replicon
sequenc
case
fulllength
defect
genom
transpackag
observ
construct
effici
greatest
turn
pseudoinfecti
particl
physic
antigen
properti
compar
observ
wt
viru
particl
densiti
similar
seen
hcvcc
particl
neutral
assay
antibodi
shown
pseudoinfecti
particl
use
glycoprotein
hcv
entri
receptor
cell
entri
ishii
et
al
observ
particl
electron
microscop
confirm
similar
hcvcc
particl
pseudoinfecti
particl
capabl
singl
round
infect
defect
genom
clearli
encapsid
sever
research
group
develop
assay
transpackag
particl
wherea
other
observ
particl
featur
estim
effici
transencapsid
variou
titr
pseudoinfecti
particl
obtain
ae
focusform
unit
ffu
ml
accord
ishii
et
al
tissu
cultur
infect
dose
tcid
ml
accord
tabl
summari
infecti
particl
gener
cotransfect
delet
subgenom
replicon
structur
protein
express
tran
packag
feasibl
express
posit
neg
nt
test
tabl
comparison
respect
system
yield
difficult
heterogen
infecti
unit
use
differ
detect
experi
sever
group
tri
improv
transpackag
system
introduc
abovement
adapt
mutat
subgenom
replicon
complement
structur
protein
region
exampl
mutat
introduc
ctermin
region
found
enhanc
product
use
replicon
li
et
al
group
insert
mutat
region
mutat
obtain
peak
titr
iuml
similar
observ
obtain
baculoviru
system
introduct
mutat
ctermin
part
core
lastli
mutat
introduc
express
plasmid
pcagc
result
fourfold
increas
pseudoparticl
product
parallel
heterolog
transpackag
assay
develop
first
group
steinmann
et
al
test
replicon
chimera
infecti
transpackag
particl
obtain
two
chimera
gave
best
yield
li
et
al
chose
heterolog
transencapsid
replicon
hcv
envelop
glycoprotein
envelop
protein
abl
rescu
pseudoinfecti
particl
product
intergenotyp
compat
envelop
protein
protein
may
essenti
assembl
process
new
cultur
system
enabl
develop
transcomplement
system
facilit
studi
genom
protein
function
ii
interact
hcv
protein
transcomplement
base
ns
region
shown
region
carri
mutat
domain
delet
domain
iii
complement
minim
sequenc
ii
effici
transcompl
wt
iii
transcomplement
exist
mutat
unstructur
region
weak
expect
genom
transcomplement
hcv
replic
system
limit
ns
hcv
protein
act
preferenti
ci
transcomplement
studi
increas
knowledg
nonstructur
protein
function
interact
hcv
demonstr
domain
iii
major
determin
hcv
assembl
involv
rna
replic
also
contribut
viru
assembl
releas
involv
viral
assembl
process
latepost
assembl
matur
step
perhap
concert
confer
infect
hcv
particl
moreov
gener
strict
ci
requir
core
region
allow
effici
transpackag
subgenom
rnarev
complex
interplay
core
gene
overal
result
confirm
ns
protein
involv
viral
assembl
releas
transcomplement
structur
region
shown
core
transcompl
wt
core
core
recruit
ns
protein
replic
complex
ldassoci
membran
recruit
critic
produc
infecti
virus
residu
import
product
infecti
virus
likewis
transcompl
sequenc
absolut
essenti
product
pseudoinfecti
hcv
particl
oper
independ
upstream
signal
sequenc
tyrosin
residu
close
conserv
dibas
motif
import
optim
viru
product
genotyp
virus
result
clarifi
role
core
ld
pseudoinfecti
particl
product
indic
step
viru
assembl
take
place
around
ld
variou
transpackag
system
develop
subgenom
replicon
structur
protein
express
tran
use
helper
replicon
helper
plasmid
stabl
cell
line
viral
vector
although
respect
ffuml
transient
express
system
effici
system
compar
directli
titr
transpackag
infecti
particl
around
ffuml
gener
lower
wt
particl
titr
ffuml
strain
nonetheless
titr
improv
introduct
adapt
mutat
favour
particl
product
defect
replicon
structur
region
express
tran
howev
limit
exist
heterolog
glycoprotein
intergenotyp
compat
seem
requir
protein
flavivirida
transcomplement
studi
enabl
product
vaccinelik
prepar
base
transpackag
particl
particular
report
envelop
glycoprotein
ern
classic
swine
fever
viru
pestiviru
complement
tran
cell
line
constitut
express
protein
pig
vaccin
defect
viral
particl
protect
lethal
challeng
virul
brescia
strain
observ
open
new
perspect
develop
modifi
liveattenu
vaccin
howev
report
vivo
vaccin
activ
neutral
antibodi
product
hcv
transcomplement
particl
one
possibl
explan
immun
studi
requir
high
infecti
titr
order
ffuml
transpackag
particl
product
low
ffuml
addit
studi
need
increas
pseudoinfecti
particl
yield
vaccin
assay
lastli
hcv
transcomplement
natur
phenomenon
observ
nativ
defect
subgenom
rna
identifi
infect
patient
encapsid
helper
virus
conclus
hcv
transcomplement
system
valuabl
tool
improv
knowledg
hcv
life
cycl
nevertheless
system
need
perfect
use
vaccin
assay
